Delivery Order SPE2DB22D3301-SPE2DB24FY4EN
Award Date 4/8/24
Potential Completion Date 4/9/24
Potential Value $2.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $11,377.22 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 8 mg Ondansetron HCL tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for AmerisourceBergen to provide...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,668.97 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to support the Department of...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $3,048.23 to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. dba AmerisourceBergen. The contract is for the delivery of Ondansetron HCL 4 mg tablets to support military treatment programs and facilities. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical sourcing and distribution company. The contract, valued at $1,143.66, is for the supply of 8 mg Ondansetron HCl tablets over a period ending on February 6, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,156.88 order is for 30-count packages of the drug Ondansetron ODT 4 mg tablet. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $2,686.75 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,563,557,459 units of Ondansetron ODT 8 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999.00, which runs through November 2026. The contract is for the provision of a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,517.44 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of 4,563,534,937 units of Ondansetron HCL 8 mg tablets, with a completion date of February 5, 2024. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract, valued at $9,280.48, is for the delivery of Ondansetron HCL 8 mg tablets and has a performance period through March 27, 2024. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $3,582.60 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is to provide 4,564,221,918 units of the pharmaceutical product Ondansetron ODT 8 mg tablets in 30-count packages. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 through December 31,...
- The U.S. Defense Logistics Agency (DLA) awarded a $6,533.85 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the Amerisourcebergen Corporation. The contract is for the supply of 4,564,325,614 units of the prescription drug Ondansetron ODT 4 mg Tablet 30s. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025....